COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

coronavirus COVID-19 vaccine vaccination

Teens are getting the COVID vaccine—even when parents say not to

With the U.S. opening approved COVID-19 vaccines to those 12 and older, teenagers are opting in on inoculations. 

 

Thumbnail

Pandemic worsened mental health conditions among healthcare workers

More than half of healthcare workers reported at least one adverse mental health condition tied to the public health crisis caused by COVID-19, new data from the CDC reveals.

A closer look at the pandemic's impact on heart attack patients

Patients presenting with an acute myocardial infarction during the start of the COVID-19 pandemic faced delays in care and a higher risk of developing heart failure.

Thumbnail

Hospitals, physician groups recovering from pandemic lows

Hospitals, health systems and physician groups saw big gains in May compared to the same month in 2020 when COVID-19 pandemic lockdown measures were in place. 

 

Remdesivir-related low heart rate reported in elderly COVID-19 patient

The patient, a 78-year-old female, began showing signs of a negative reaction within 20 hours. 

FDA announces a new myocarditis warning for COVID-19 vaccines as specialists urge Americans to get vaccinated

In a new statement, the CDC, American Heart Association and several other healthcare organizations highlighted the continued importance of vaccination. 

heart vaccine myocarditis covid-19

Moderna, Pfizer vaccines will add rare heart inflammation warning

A number of cases of heart inflammation will lead the FDA to slap a new warning label on two COVID-19 vaccines available in the U.S.—the ones from Pfizer-BioNTech and Moderna.

An encouraging update: Young adults with vaccine-related heart damage see all symptoms resolve

“Given the potential morbidity of COVID-19 infection even in younger adults, the risk-benefit decision for vaccination remains highly favorable," researchers wrote.